GlaxoSmithKline PD-1 hopeful dostarlimab fell victim to COVID-related inspection delay: report

GlaxoSmithKline PD-1 hopeful dostarlimab fell victim to COVID-related inspection delay: report
fkansteiner
Wed, 01/20/2021 – 09:52